1[1]Hu j, Gardner MB and Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells [J] .J Virol, 2000, 74(13): 6087.
2[2]Alfeld M and Rosenberg ES. The role of CD4 ( + ) T helper cells in the cytotoxic T lymphocyte response to HIV-1 [J] .Curr Opin Immunol. 2000,12(4): 375.
3[3]Malhotra U, Holte S, Dutta S and Berrey MM et al. Role for HLA class Ⅱ molecules in HⅣ-1 suppression and cellular immunity following antiretroviral treatment [J]. J Clin Invest, 2001,107(4): 505.
4[4]Lifson JD, Rossin JL and Piatak M Jr et al. Role of CD8( + )lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment [J]. J Virol, 2001, 75(21): 10187.
5[5]Hel Z, Venzon D and Poudyal M et al. Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection tof macaques [J]. Nat Med, 2000, 6 (10): 1140.
6[6]Lori F, Lewis MG and Xu J et al. Control of SIV rebound through structured treatment interruptions during early infection [J]. Science,2000, 290(5496): 1591.
7[7]Li J, Lord CI and Haseltine W et al. Infection of cynomolgus monkeys with a chimeric HIV-1/SIV virus that expresses the HIV-1 envelope glycoproteins [J] . J Acquired Immune Defic Syndr, 1992.5: 639.
8[8]Shibata R, Igarashi T and Haigwood N et al. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys [J] .Nat Med, 1999, 5(2) :204.
9[9]Baba TW, Liska V and Hofmann-Lehmann R et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J]. Nat Med, 2000, 6(2) :200.
10[10]Mascola JR, Stiegler G and VanCott TC et al. Protection of macaques against vaginal transmission of a pathogenic HⅣ-1/SⅣ chimeric virus by passive infusion of neutralizing antibodies [J] . Nat Med, 2000, 6(2) :207.
9Green TD,Montefiori DC.Enhancement of antibodies to the human immunodeficiency virus typel envelope by using the molecular adjuvant C3d[J].J Virology,2003,77(3):2046～2055
10Muthumani K,Bagarazzi M,Conw AY D,et al.A Gag-PO1/EnvRev SIV239 DNA vaccine improves CD4 counts,and reduce viral loads after pathogenic intrarectal SIV(mac)251challenge in rhesus Macaques[J].Vaccine,2003,21 (7):629～637
